US4660563A
Expired / Lapsed
US
⏱️ 0.0 years remaining
Method and means for detection of arterial lesions
Assignee: Massachusetts Institute of Technology
•
Filing: 1985-09-11
•
Granted: 1987-04-28
•
Expires: 2005-09-11
Abstract
Abstract The atherosclerotic plaques which form arterial lesions have been found to take up lipoproteins from the blood flowing through the arteries. Accordingly, the early detection of arterial disease is accomplished by preparing an infusate composed of radiolabeled low-density lipoproteins and introducing the infusate into the patient's arterial system. A gamma radiation detector is then used to detect and quantify concentrations of the radiolabeled proteins thereby to indicate the locations and sizes of the lesions.
Inventors
- 👤 Robert S. Lees
Bibliographic Details
Application Number
—
Jurisdiction
US
Data Source
google_patents
Last Synchronized
2026-10-23 14:31
CPC Classifications
A; A61; A61B; A61B6/00; A61B6/40; A61B6/4057; A61B6/42; A61B6/4208; A61B6/4258; A61K; A61K51/00; A61K51/12; A61K51/1217; A61K51/1224; A61K2123/00
Claims Analysis
Total Claims: 10
Claim 1
Independent Claim
102 words
The method for the early detection of arterial disease including atherosclerosis comprising the steps of A. preparing an infusate composed of 1. low density lipoproteins, and 2. tracer means linked to said proteins and capable of being viewed extracorporeally, B. injecting the infusate into the vascular system of a patient; C. subsequently viewing the patient's vascular system with extracorporeally-located detecting means capable of detecting the tracer means; D. determining from said detecting means the locations of tracer means in the patient's vascular system; and E. quantifying concentrations of the tracer means by said detecting means at one or more of said locations.
Claim 2
Independent Claim
102 words
The method for the early detection of arterial disease including atherosclerosis comprising the steps of A. preparing an infusate composed of 1. low density lipoproteins, and 2. tracer means linked to said proteins and capable of being viewed extracorporeally, B. injecting the infusate into the vascular system of a patient; C. subsequently viewing the patient's vascular system with extracorporeally-located detecting means capable of detecting the tracer means; D. determining from said detecting means the locations of tracer means in the patient's vascular system; and E. quantifying concentrations of the tracer means by said detecting means at one or more of said locations.
Claim 3
Dependent Claim
22 words
The method defined in claim 1 wherein the infusate is prepared from lipoproteins having a density of from 1.025 to 1.050 gm/ml.
Claim 4
Dependent Claim
36 words
The method defined in claim 1 wherein A. The infusate is preapred from tracer means composed of a radionuclide; and B. the determining step is accomplished by viewing the vascular system with a gamma radiation detector.
Claim 5
Dependent Claim
25 words
The method defined in claim 3 wherein the infusate is prepared from a radionuclide selected from the class consisting of Tc-99m, In-111, I-125 and I-123.
Claim 6
Dependent Claim
76 words
Apparatus for detecting vascular disease comprising A. an infusate for infusing into the vascular system of a patient, said infusate including 1. low density blood lipoproteins having a selected density range; and 2. tracer means linked to said proteins and capable of being viewed estracorporeally; B. tracer detecting means for positioning opposite the patient's body to detect concentrations of said tracer means in said vascular system; and C. means for quantifying the detected tracer means concentrations.
Claim 7
Dependent Claim
76 words
Apparatus for detecting vascular disease comprising A. an infusate for infusing into the vascular system of a patient, said infusate including 1. low density blood lipoproteins having a selected density range; and 2. tracer means linked to said proteins and capable of being viewed estracorporeally; B. tracer detecting means for positioning opposite the patient's body to detect concentrations of said tracer means in said vascular system; and C. means for quantifying the detected tracer means concentrations.
Claim 8
Dependent Claim
17 words
The apparatus defined in claim 5 wherein the lipoproteins have a density of 1.025 to 1.050 gm/ml.
Claim 9
Dependent Claim
23 words
The apparatus defined in claim 5 wherein A. the tracer means is a radionuclide; and B. the detecting means responds to gamma radiation.
Claim 10
Dependent Claim
21 words
The apparatus defined in claim 7 wherein the radionuclide is selected from the group consisting of Tc-99m, In-111, I-125 or I-123.
References Cited (Backward Citations)
US4359453A
Cited
US4343734A
Cited
USPTO Annuity & Maintenance Windows
| Annuity Stage | Window Opens | Payment Deadline | Surcharge Period Until | Estimated Fee | Status |
|---|---|---|---|---|---|
| 3.5 Years (Year 4) | 1990-04-27 | 1990-10-27 | 1991-04-28 | $2000.00 | Window Closed / Lapsed |
| 7.5 Years (Year 8) | 1994-04-27 | 1994-10-27 | 1995-04-28 | $3760.00 | Window Closed / Lapsed |
| 11.5 Years (Year 12) | 1998-04-27 | 1998-10-27 | 1999-04-28 | $7700.00 | Window Closed / Lapsed |